These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 772172)

  • 1. Post-detoxification drug treatment of anxiety and depression in alcohol addicts.
    Hague WH; Wilson LG; Dudley DL; Cannon DS
    J Nerv Ment Dis; 1976 May; 162(5):354-9. PubMed ID: 772172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Melatonin Upon Postacute Withdrawal Among Males in a Residential Treatment Program (M-PAWS): A Randomized, Double-blind, Placebo-controlled Trial.
    Bondi CD; Kamal KM; Johnson DA; Witt-Enderby PA; Giannetti VJ
    J Addict Med; 2018; 12(3):201-206. PubMed ID: 29351138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzoctamine and oxazepam in the management of alcohol withdrawal states. Comparison by double-blind trial.
    Gillmer RE
    S Afr Med J; 1973 Dec; 47(47):2267-8. PubMed ID: 4588385
    [No Abstract]   [Full Text] [Related]  

  • 5. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
    Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
    Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood-altering effects of disulfiram in alcoholics.
    Goyer PF; Brown GL; Minichiello MD; Major LF
    J Stud Alcohol; 1984 May; 45(3):209-13. PubMed ID: 6748661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alleviating agitation, apprehension, and related symptoms in geriatric patients: A double-blind comparison of a phenothiazine and a benzodiazepien.
    Covington JS
    South Med J; 1975 Jun; 68(6):719-24. PubMed ID: 1094544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations.
    Le Bon O; Murphy JR; Staner L; Hoffmann G; Kormoss N; Kentos M; Dupont P; Lion K; Pelc I; Verbanck P
    J Clin Psychopharmacol; 2003 Aug; 23(4):377-83. PubMed ID: 12920414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison of thioridazine (Mellaril) versus diazepam (valium) in patients with chronic mixed anxiety and depressive symptoms.
    Rosenthal SH; Bowden CL
    Curr Ther Res Clin Exp; 1973 May; 15(5):261-7. PubMed ID: 4196786
    [No Abstract]   [Full Text] [Related]  

  • 10. Thioridazine HC1 Vs. chlordiazepoxide HC1 in controlling symptoms attributable to alcohol withdrawal.
    Pena-Ramos A
    Dis Nerv Syst; 1977 Mar; 38(3):143-7. PubMed ID: 837817
    [No Abstract]   [Full Text] [Related]  

  • 11. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the efficacy and tolerability of clobazam and chlordiazepoxide in the treatment of acute withdrawal from alcohol in patients with primary alcoholism.
    Mukherjee PK
    J Int Med Res; 1983; 11(4):205-11. PubMed ID: 6137426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of psychoactive drugs in the long-term treatment of chronic alcoholics.
    Kissin B
    Ann N Y Acad Sci; 1975 Apr; 252():385-95. PubMed ID: 238453
    [No Abstract]   [Full Text] [Related]  

  • 14. Thioridazine in the treatment of depressive patients.
    de Jonghe FE; Schalken HF; van der Helm HJ
    Acta Psychiatr Scand; 1976 Apr; 53(4):271-6. PubMed ID: 775889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter study comparing thioridazine with diazepam and placebo in elderly, nonpsychotic patients with emotional and behavioral disorders.
    Stotsky B
    Clin Ther; 1984; 6(4):546-59. PubMed ID: 6380725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical study of clobazam in alcohol detoxification [proceedings].
    Méry C; Martin JC
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):133S. PubMed ID: 35195
    [No Abstract]   [Full Text] [Related]  

  • 17. The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification.
    Malcolm R; Myrick H; Roberts J; Wang W; Anton RF
    Am J Addict; 2002; 11(2):141-50. PubMed ID: 12028744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMPI and drug treatment in alcohol withdrawal.
    Pena-Ramos A; Hornberger R
    J Clin Psychiatry; 1979 Aug; 40(8):361-4. PubMed ID: 468763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
    Huang MC; Chen CH; Pan CH; Lin SK
    J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apomorphine and psychopathology.
    Lal S; De la Vega CE
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):722-6. PubMed ID: 1099172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.